Liquidia Corporation (LQDA)
NASDAQ: LQDA · IEX Real-Time Price · USD
11.83
-0.21 (-1.74%)
At close: Jul 2, 2024, 4:00 PM
11.84
+0.01 (0.08%)
After-hours: Jul 2, 2024, 6:43 PM EDT

Liquidia Revenue

Liquidia had revenue of $15.97M in the twelve months ending March 31, 2024, down -5.72% year-over-year. Revenue in the quarter ending March 31, 2024 was $2.97M, a -33.85% decrease year-over-year. In the year 2023, Liquidia had annual revenue of $17.49M with 9.75% growth.

Revenue (ttm)
$15.97M
Revenue Growth
-5.72%
P/S Ratio
56.62
Revenue / Employee
$110,117
Employees
145
Market Cap
903.98M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202317.49M1.55M9.75%
Dec 31, 202215.94M3.08M23.98%
Dec 31, 202112.85M12.11M1,637.77%
Dec 31, 2020739.63K-7.33M-90.84%
Dec 31, 20198.07M5.37M198.20%
Dec 31, 20182.71M-4.55M-62.70%
Dec 31, 20177.26M-5.96M-45.08%
Dec 31, 201613.22M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
OPKO Health 799.60M
Avanos Medical 680.10M
Maravai LifeSciences Holdings 274.10M
BioLife Solutions 137.30M
Cronos Group 93.03M
Simulations Plus 64.67M
Tango Therapeutics 37.23M
Silence Therapeutics 33.86M
Revenue Rankings